Characterization of two distinct mechanisms for induction of apoptosis in human vascular endothelial cells

Clinical Chemistry and Laboratory Medicine

Volumn 37, Issue 5, 1999, Pages 505-510

  Gräfe, Michael ^a,c   Steinheider, Gerhard ^b   Desaga, Ulrike ^a   Warnecke, Christina ^a   Lehmkuhl, Hans B ^a   Regitz Zagrosek, Vera ^a   Hildebrandt, Alfred G ^b   Fleck, Eckart ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

^b Federal Institute for Drugs and Medical Devices   (Germany)

^c DEUTSCHES HERZZENTRUM BERLIN   (Germany)

Author keywords

Actinomycin D; Apoptosis; Endothelium

Indexed keywords

DACTINOMYCIN; DNA FRAGMENT; DNA NUCLEOTIDYLEXOTRANSFERASE; GROWTH FACTOR; PYRROLIDINE DITHIOCARBAMATE;

APOPTOSIS; ARTICLE; CELL CULTURE; DNA DEGRADATION; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; FLUORESCENCE ACTIVATED CELL SORTER; HUMAN; HUMAN CELL; NUCLEOSOME; PRIORITY JOURNAL; SERUM; VASCULAR ENDOTHELIUM;

ANTIOXIDANTS; APOPTOSIS; CELL SEPARATION; CELLS, CULTURED; CYCLOHEXIMIDE; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ENDOTHELIUM, VASCULAR; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMANS; PROTEIN SYNTHESIS INHIBITORS; PYRROLIDINES; THIOCARBAMATES;

EID: 0033006238     PISSN: 14346621     EISSN: None     Source Type: Journal    
DOI: 10.1515/CCLM.1999.081     Document Type: Article

References (47)

1. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993; 362:801-9.
2. Pober JS, Cotran RS. The role of endothelial cells in inflammation. Transplantation 1990; 50:537-44.
3. Bauriedel G, Schluckebier S, Welsch U, Klingel K, Kandolf R, Steinbeck G. Frequency and localization of apoptotic bodies in human arteriosclerosis. Z. Kardiol 1996; 85:509-18.
4. Weinberger MS, Davidson TM, Broide DH. Differential expression of vascular cell adhesion molecule mRNA and protein in nasal mucosa in response to IL-1 or tumor necrosis factor. J Allergy Clin Immunol 1996; 97:662-71.
5. Isner JM, Kearney M, Bortman S, Passeri J. Apoptosis in human atherosclerosis and restenosis. Circulation 1995; 91:2703-11.
6. Wyllie AH. Apoptosis: cell death under homeostatic control. Arch Toxicol 1987; 11 (Suppl):3-10.
7. Martin SJ, Green DR, Cotter TG. Dicing with death: dissecting the components of the apoptosis machinery. Trends Pharmacol Sci 1994; 19:26-30.
8. Schwartz LM, Smith SW, Jones MEE, Osborne BA. Do all programmed cell deaths occur via apoptosis. Proc Natl Acad Sci USA 1993; 90:980-4.
9. Cotter TG, Glynn JM, Echeverri F, Green DR. The induction of apoptosis by chemotherapeutic agents occurs in all phases of the cell cycle. Anticancer Res 1992; 12:773-80.
10. Verhaegen S, McGowan AJ, Brophy AR, Fernandes RS, Cotter TG. Inhibition of apoptosis by antioxidants in the human HL-60 leukemia cell line. Biochem Pharmacol 1995; 50:1021-9.
11. Bessho R, Matsubara K, Kubota M, Kuwakado K, Hirota H, Wakazono Y, et al. Pyrrolidine dithiocarbamate, a potent inhibitor of nuclear factor kappa B (NF-kappa B) activation, prevents apoptosis in human promyelocytic leukemia HL-60 cells and thymocytes. Biochem Pharmacol 1994; 48:1883-9.
12. Jaffe EA, Nachman RL, Becker CG, Minick CR. Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. J Clin Invest 1973; 52:2745-56.
13. Franke RP, Gräfe M, Schnittler H, Seiffge D, Mittermayer C, Drenckhahn D. Induction of human vascular endothelial stress fibres by fluid shear stress. Nature 1984; 307:648-9.
14. Voyta JC, Via DP, Butterfield CE, Zetter BR. Identification and isolation of endothelial cells based on their increased uptake of acetylated-low density lipoprotein. J Cell Biol 1984; 99:2034-40.
15. Rosi F. A simple and rapid method for detection of apoptosis in human cells. Nucleic Acids Res 1992; 20:5243.
16. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the folin phenol reagent. J Biol Chem 1951; 193:265-75.
17. Dignam JD, Lebovitz RM, Roeder RG. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucl Acids Res 1983; 11:1475-89.
18. Bradford MM. A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72:248-54.
19. Whelan J, Ghersa P, van Huijsduijnen RH, Gray J, Chandra G, Talabot F, et al. An NF-κB-like factor is essential but not sufficient for cytokine induction of endothelial leukocyte adhesion molecule 1 (ELAM-1) gene transcription. Nucl Acids Res 1991; 19:2645-53.
20. Araki S, Simada Y, Kaji K, Hayashi H. Role of protein kinase C in the inhibition by fibroblast growth factor of apoptosis in serum depleted endothelial cells. Biochem Biophys Res Commun 1990; 172:1081-5.
21. Schreck R, Meier B, Mannel DN, Droge W, Baeuerle PA. Dithiocarbamates as potent inhibitors of nuclear factor kappa B activation in intact cells. J Exp Med 1992; 175:1181-94.
22. Gerschenson LE, Rotello RJ. Apoptosis: a different type of cell death. FASEB J 1992; 6:2450-5.
23. James TN. Normal and abnormal consequences of apoptosis in the human heart. Circulation 1997; 90:556-73.
24. Desmouliere A, Badid C, Bochaton-Piallat ML, Gabbiani G. Apoptosis during wound healing, fibrocontractive diseases and vascular wall injury, Int J Biochem Cell Biol 1997; 29:19-30.
25. Kyprianou N, English HF, Davidson NE, Isaacs JT. Programmed cell death during regression of the MCF-7 human breast cancer following estrogen ablation. Cancer Res 1991; 51:162-6.
26. Winoto A. Cell death in the regulation of immune responses. Curr Opin lmmunol 1997; 9:365-70.
27. Kockx MM, De MG, Muhring J, Jacob W, Bult H, Herman AG. Apoptosis and related proteins in different stages of human atherosclerotic plaques. Circulation 1998; 97:2307-15.
28. Perlman H, Maillard L, Krasinski K, Walsh K. Evidence for the rapid onset of apoptosis in medial smooth muscle cells after balloon injury. Circulation 1997; 95:981-7.
29. Wyllie AH, Morris RG, Smith AL, Dunlop D. Chromatin cleavage in apoptosis: association with condensed chromatin morphology and dependence on macromolecular synthesis. J Pathol 1984; 142:67-77.
30. Gavrieli Y, Sherman Y, Ben-Sasson SA. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 1992; 119:493-501.
31. Gold R, Schmied M, Giegerich G, Breitschopf H, Hartung HP, Toyka KV, et al. Differentiation between cellular apoptosis and necrosis by the combined use of in situ tailing and nick translation techniques. Lab Invest 1994; 71:219-25.
32. Kockx MM, Muhring J, Knaapen MW, De MG. RNA synthesis and splicing interferes with DNA in situ end labeling techniques used to detect apoptosis. Am J Pathol 1998; 152:885-8.
33. Meredith JE, Fazeli B, Schwartz MA. The extracellular matrix as cell survival factor. Mol Biol Cell 1993; 4:953-61.
34. Brindle NP. Growth factors in endothelial regeneration. J Cardiovasc Res 1993; 27:1162-72.
35. Rivard A, Fabre JE, Silver M, Chen D, Murohara T, Kearney M, et al. Age-dependent impairment of angiogenesis. Circulation 1999; 99:111-20.
36. Nebert DW, Gelboin HV. The role of ribonucleic acid and protein synthesis in microsomal aryl hydrocarbon hydroxylase induction in cell culture. The independence of transcription and translation. J Biol Chem 1970; 245:160-8.
37. Liu LF. DNA topoisomerase poisons as antitumor drugs. Annu Rev Biochem 1989; 58:351-75.
38. Sunderman FW. Therapeutic properties of sodium diethyldithiocarbamate: its role as an inhibitor in the progression of AIDS. Ann Clin Lab Sci 1991; 21:70-81.
39. Ziegler-Heitbrock HW, Sternsdorf T, Liese J, Belohradsky B, Weber C, Wedel A, et al. Pyrrolidine dithiocarbamate inhibits NF-kappa B mobilization and TNF production in human monocytes. J Immunol 1993; 151:6986-93.
40. Hockenbery DM, Oltvai ZN, Yin X-M, Milliman CL, Korsmeyer SJ. Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell 1993; 75:241-51.
41. Shoji Y, Uedono Y, Ishikura H, Takeyama N, Tanaka T. DNA damage induced by tumour necrosis factor-alpha in L929 cells is mediated by mitochondrial oxygen radical formation, Immunol 1995; 84:543-8.
42. Sarvazyan N. Visualization of doxorubicin-induced oxidative stress in isolated cardiac myocytes. Am J Physiol 1996; 271:H2079-H85.
43. Andrivon W, Saucier JM, Auclair C, Monneret C, Florent JC, Guillosson JJ, et al. Enhanced topoisomerase II-induced DNA breaks and free radical production by a new anthracycline with potent antileukemic activity. Leuk Res 1996; 20:119-26.
44. Powell CB, Herzog TJ, Scott JH, Collins JL. Evidence for a protein synthesis-dependent and -independent TNF alpha cytolytic mechanism. Gynecol Oncol 1995; 58:327-35.
45. Ruef J, Hu ZY, Yin LY, Wu Y, Hanson SR, Kelly AB, et al. Induction of vascular endothelial growth factor in balloon-injured baboon arteries. A novel role for reactive oxygen species in atherosclerosis. Circ Res 1997; 81:24-33.
46. Dimmeler S, Haendeler J, Nehls M, Zeiher AM. Suppression of apoptosis by nitric oxide via inhibition of interleukin-1beta-converting enzyme (ICE)-like and cysteine protease protein (CPP)-32-like proteases. J Exp Med 1997; 185:601-7.
47. Traenckner EB, Wilk S, Baeuerle PA. A proteasome inhibitor prevents activation of NF-kappa B and stabilizes a newly phosphorylated form of I kappa B-alpha that is still bound to NF-kappa B. EMBO J 1994; 13:5433-41.